Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review
出版年份 2021 全文链接
标题
Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review
作者
关键词
-
出版物
Journal of Orthopaedic Surgery and Research
Volume 16, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-31
DOI
10.1186/s13018-021-02497-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
- (2019) Mattias Lorentzon et al. ADVANCES IN THERAPY
- Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
- (2019) D.L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial
- (2019) Joy N Tsai et al. Lancet Diabetes & Endocrinology
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Associations between bone-alkaline phosphatase and bone mineral density in adults with and without diabetes
- (2018) Hailing Chen et al. MEDICINE
- Retraction: Paper “Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis” by Iwamoto J, et al. [Yonsei Med J 2008;49(1):119-128]
- (2018) YONSEI MEDICAL JOURNAL
- Use of bone turnover markers in the management of osteoporosis
- (2018) Sumeet Jain et al. Current Opinion in Endocrinology Diabetes and Obesity
- DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
- (2017) Richard Eastell et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble
- (2017) Vasilis Kontis et al. LANCET
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- Use of bone turnover markers in postmenopausal osteoporosis
- (2017) Richard Eastell et al. Lancet Diabetes & Endocrinology
- Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study
- (2017) Bo-cheng Liang et al. Orthopaedic Surgery
- The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
- (2017) Elma Kučukalić-Selimović et al. Bosnian Journal of Basic Medical Sciences
- Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population
- (2016) Zhaoli Dai et al. BONE
- Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease
- (2016) Matthew B. Greenblatt et al. CLINICAL CHEMISTRY
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postmenopausal Osteoporosis
- (2016) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting
- (2015) James E Bennett et al. LANCET
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
- (2015) A. D. Anastasilakis et al. OSTEOPOROSIS INTERNATIONAL
- Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
- (2015) Rinaldo Florencio-Silva et al. Biomed Research International
- Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women
- (2015) Susan L. Greenspan et al. JAMA Internal Medicine
- Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women
- (2014) S. Gonnelli et al. BONE
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
- (2014) J. P. Brown et al. OSTEOPOROSIS INTERNATIONAL
- Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
- (2014) M. A. Paggiosi et al. OSTEOPOROSIS INTERNATIONAL
- Biochemical markers of bone turnover – uses and limitations
- (2014) Thinn Thinn Hlaing et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis
- (2013) Núria Guañabens et al. HEPATOLOGY
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- Use of bone turnover markers in clinical practice
- (2013) Emmanuel Biver Current Opinion in Endocrinology Diabetes and Obesity
- Benefits and Risks of Bisphosphonate Therapy for Osteoporosis
- (2012) Sundeep Khosla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study
- (2012) J. Tamaki et al. OSTEOPOROSIS INTERNATIONAL
- Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
- (2011) Z. Sanad et al. CLIMACTERIC
- The potential value of monitoring bone turnover markers among women on alendronate
- (2011) Katy JL Bell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized Controlled Trial
- (2011) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of biochemical markers of bone turnover in paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links
- (2010) A.G. Randall et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
- (2010) A. Michael Parfitt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
- (2010) Dennis A. Hanson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis
- (2010) J. Iwamoto et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
- (2009) Yoon-Sok Chung et al. CALCIFIED TISSUE INTERNATIONAL
- Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study
- (2009) Douglas C Bauer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass
- (2009) Michael McClung et al. OBSTETRICS AND GYNECOLOGY
- Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
- (2009) P. J. Meunier et al. OSTEOPOROSIS INTERNATIONAL
- Bone turnover markers: understanding their value in clinical trials and clinical practice
- (2009) R. Civitelli et al. OSTEOPOROSIS INTERNATIONAL
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States
- (2008) Sarah J Glover et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women
- (2008) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
- (2008) Jun Iwamoto et al. YONSEI MEDICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now